These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38180429)

  • 1. Gender and Race Differences in HeartMate3 Left Ventricular Assist Device as a Bridge to Transplantation.
    Steinberg RS; Okoh AK; Wang J; Patel KJ; Gangavelli A; Nayak A; Ko YA; Gupta D; Daneshmand M; Vega JD; Morris AA
    JACC Heart Fail; 2024 Aug; 12(8):1459-1469. PubMed ID: 38180429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Outcomes After Heart Transplantation in Recipients Bridged With a HeartMate 3 Device.
    Suarez-Pierre A; Lui C; Zhou X; Crawford TC; Fraser CD; Giuliano K; Hsu S; Higgins RS; Zehr KJ; Whitman GJ; Choi CW; Kilic A
    Ann Thorac Surg; 2019 Aug; 108(2):467-473. PubMed ID: 30880137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparities and outcomes of left ventricular assist device implantation as a bridge to heart transplantation.
    Okoh AK; Selevanny M; Singh S; Hirji S; Singh S; Al Obaidi N; Lee LY; Camacho M; Russo MJ
    ESC Heart Fail; 2020 Oct; 7(5):2744-2751. PubMed ID: 32627939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-Related Differences in Use and Outcomes of Left Ventricular Assist Devices as Bridge to Transplantation.
    DeFilippis EM; Truby LK; Garan AR; Givens RC; Takeda K; Takayama H; Naka Y; Haythe JH; Farr MA; Topkara VK
    JACC Heart Fail; 2019 Mar; 7(3):250-257. PubMed ID: 30819381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in Donor Heart Acceptance by Race and Gender of Patients on the Transplant Waiting List.
    Breathett K; Knapp SM; Lewsey SC; Mohammed SF; Mazimba S; Dunlay SM; Hicks A; Ilonze OJ; Morris AA; Tedford RJ; Colvin MM; Daly RC
    JAMA; 2024 Apr; 331(16):1379-1386. PubMed ID: 38526480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased frequency of transplantation and lower post-transplant survival free of re-transplantation in LVAD patients with the new heart transplant allocation system.
    Jani M; Lee S; Acharya D; Hoeksema S; Boeve T; Leacche M; Manandhar-Shrestha NK; Jovinge SV; Loyaga-Rendon RY
    Clin Transplant; 2022 Jan; 36(1):e14493. PubMed ID: 34689383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Tale of Two Centrifugal-Flow Ventricular Assist Devices As Bridge to Heart Transplant.
    Alwair H; Whitehouse K; Slaughter MS; Trivedi JR
    Ann Thorac Surg; 2022 Mar; 113(3):757-762. PubMed ID: 33857496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Use of Left Ventricular Assist Devices as Bridge to Transplantation With New Heart Allocation Policy.
    Mullan CW; Chouairi F; Sen S; Mori M; Clark KAA; Reinhardt SW; Miller PE; Fuery MA; Jacoby D; Maulion C; Anwer M; Geirsson A; Mulligan D; Formica R; Rogers JG; Desai NR; Ahmad T
    JACC Heart Fail; 2021 Jun; 9(6):420-429. PubMed ID: 33714748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HeartMate 3 left ventricular assist device as a strategy to bridge to transplant.
    Kilcoyne MF; Huckaby LV; Hashmi Z; Witer L; Pope N; Houston BA; Inampudi C; Tedford RJ; Kilic A
    J Card Surg; 2022 Dec; 37(12):4713-4718. PubMed ID: 36321713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular assist device is protective against cardiac transplant delisting for medical unsuitability.
    Cogswell R; Duval S; John R
    Int J Cardiol; 2018 Oct; 268():51-54. PubMed ID: 29803342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Third-generation continuous-flow left ventricular assist devices: a comparative outcome analysis by device type.
    Mihalj M; Heinisch PP; Schober P; Wieser M; Martinelli M; de By TMMH; Schefold JC; Luedi MM; Kadner A; Carrel T; Mohacsi P; Hunziker L; Reineke D
    ESC Heart Fail; 2022 Oct; 9(5):3469-3482. PubMed ID: 35880515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Socioeconomic Status on Patients Supported With a Left Ventricular Assist Device: An Analysis of the UNOS Database (United Network for Organ Sharing).
    Clerkin KJ; Garan AR; Wayda B; Givens RC; Yuzefpolskaya M; Nakagawa S; Takeda K; Takayama H; Naka Y; Mancini DM; Colombo PC; Topkara VK
    Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality.
    Truby LK; Farr MA; Garan AR; Givens R; Restaino SW; Latif F; Takayama H; Naka Y; Takeda K; Topkara VK
    Circulation; 2019 Aug; 140(6):459-469. PubMed ID: 31203669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality in status 2 patients listed for heart transplantation in the United States: Will understanding cause of death help justify implantation of left ventricular assist devices into less sick patients?
    Morris AA; Chen C; Laskar SR; Smith AL; Vega JD
    Int J Cardiol; 2019 Feb; 276():185-190. PubMed ID: 30482444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the OPTN policy change on patients with a durable left ventricular assist device and chronic kidney disease: Analysis of the UNOS database.
    Warner ED; Pritting C; Dutta S; Bierowski M; Ullah W; Brailovsky Y; Kittleson M; Alvarez RJ; Rame JE; Hajduczok A; Kumar V; Ahmad D; Tchantchaleishvili V; Rajapreyar IN
    Artif Organs; 2024 Oct; 48(10):1180-1189. PubMed ID: 38803277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Contemporary Use of Ventricular Assist Devices in Children Awaiting Heart Transplantation and Their Outcomes by Race/Ethnicity.
    Trivedi J; Slaughter MS; Moskowitz WB; Ghaleb S; Das BB
    ASAIO J; 2023 Feb; 69(2):210-217. PubMed ID: 35438653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective organ procurement and transplantation network status 1A time.
    Dardas T; Mokadam NA; Pagani F; Aaronson K; Levy WC
    J Am Coll Cardiol; 2012 Jul; 60(1):36-43. PubMed ID: 22541833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of total artificial heart and biventricular assist device support as bridge-to-transplantation.
    Cheng A; Trivedi JR; Van Berkel VH; Massey HT; Slaughter MS
    J Card Surg; 2016 Oct; 31(10):648-653. PubMed ID: 27573150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.